• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桥本甲状腺炎合并甲状腺乳头状癌的术前超声特征对中央区淋巴结转移的预测。

Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.

机构信息

Department of Ultrasound Diagnosis, The Second Xiangya Hospital, Central South University, Changsha, China.

Research Center of Ultrasonography, The Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Endocrinol (Lausanne). 2021 Mar 15;12:556851. doi: 10.3389/fendo.2021.556851. eCollection 2021.

DOI:10.3389/fendo.2021.556851
PMID:33796065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8008373/
Abstract

The purpose of this study was to evaluate the usefulness of the sonographic characteristics of papillary thyroid carcinoma (PTC) with Hashimoto's thyroiditis (HT) for predicting central lymph node metastasis (CLNM). One hundred thirty-three patients who underwent thyroidectomy and central cervical lymph node dissection for PTC with coexistent HT were retrospectively analyzed. All PTCs with HT were preoperatively evaluated by ultrasound (US) regarding their nodular number, size, component, shape, margin, echogenicity, calcification, capsule contact with protrusion, vascularity and contrast enhanced ultrasound (CEUS) parameters. Univariate analysis demonstrated that patients with PTCs with HT and CLNM more frequently had age ≤ 45 years, size > 10 mm, a wider than tall shape, microcalcification, hypo-enhancement and peak intensity index < 1 than those without CLNM (all <0.05). Binary logistic regression analysis demonstrated that size > 10 mm and CEUS hypo-enhancement were independent characteristics for the presence of CLNM. Our study indicated that preoperative US characteristics could offer help in predicting CLNM in PTCs with coexistent HT.

摘要

本研究旨在评估桥本甲状腺炎(HT)合并甲状腺乳头状癌(PTC)的超声特征在预测中央淋巴结转移(CLNM)中的作用。回顾性分析了 133 例因 PTC 合并 HT 而行甲状腺切除术和中央颈部淋巴结清扫术的患者。所有合并 HT 的 PTC 均在术前通过超声(US)评估结节数量、大小、成分、形状、边缘、回声、钙化、与突出物的包膜接触、血管生成和对比增强超声(CEUS)参数。单因素分析表明,有 CLNM 的 HT 合并 PTC 患者的年龄≤45 岁、大小>10mm、宽高比>1、微钙化、低增强和峰值强度指数<1 的比例高于无 CLNM 者(均<0.05)。二元逻辑回归分析表明,大小>10mm 和 CEUS 低增强是 CLNM 存在的独立特征。本研究表明,术前 US 特征有助于预测合并 HT 的 PTC 中的 CLNM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/c1391ff13dbc/fendo-12-556851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/41a414786eda/fendo-12-556851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/64f09586b69b/fendo-12-556851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/b2c264feedd3/fendo-12-556851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/c1391ff13dbc/fendo-12-556851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/41a414786eda/fendo-12-556851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/64f09586b69b/fendo-12-556851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/b2c264feedd3/fendo-12-556851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8008373/c1391ff13dbc/fendo-12-556851-g004.jpg

相似文献

1
Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.桥本甲状腺炎合并甲状腺乳头状癌的术前超声特征对中央区淋巴结转移的预测。
Front Endocrinol (Lausanne). 2021 Mar 15;12:556851. doi: 10.3389/fendo.2021.556851. eCollection 2021.
2
The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.桥本甲状腺炎共存对甲状腺乳头状癌中央区淋巴结转移的影响。
Front Endocrinol (Lausanne). 2021 Nov 16;12:772071. doi: 10.3389/fendo.2021.772071. eCollection 2021.
3
Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: a practical nomogram based on retrospective study.预测合并桥本甲状腺炎的乳头状甲状腺癌中央区颈淋巴结转移:基于回顾性研究的实用列线图
PeerJ. 2024 Apr 19;12:e17108. doi: 10.7717/peerj.17108. eCollection 2024.
4
A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.桥本甲状腺炎合并甲状腺乳头状癌中央区淋巴结转移的综合预测模型:BRAF 可能不是一个有价值的预测指标。
Front Endocrinol (Lausanne). 2024 Sep 19;15:1429382. doi: 10.3389/fendo.2024.1429382. eCollection 2024.
5
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.
6
Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer.桥本甲状腺炎对甲状腺乳头状癌颈部淋巴结病变术前超声诊断效能的综合分析。
Front Endocrinol (Lausanne). 2023 Jan 12;13:987906. doi: 10.3389/fendo.2022.987906. eCollection 2022.
7
A nomogram based on the risk factors of cervical lymph node metastasis in papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.基于甲状腺乳头状癌合并桥本甲状腺炎颈淋巴结转移风险因素的列线图。
Clin Hemorheol Microcirc. 2023;85(3):235-247. doi: 10.3233/CH-221673.
8
Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.桥本甲状腺炎与经典型甲状腺乳头状癌中央区淋巴结转移相关:来自大容量单中心经验的分析。
Front Endocrinol (Lausanne). 2022 May 20;13:868606. doi: 10.3389/fendo.2022.868606. eCollection 2022.
9
Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.术前预测桥本甲状腺炎合并甲状腺乳头状癌患者中央区淋巴结转移
Front Endocrinol (Lausanne). 2021 Jul 22;12:713475. doi: 10.3389/fendo.2021.713475. eCollection 2021.
10
Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.桥本甲状腺炎背景下甲状腺乳头状癌的淋巴结转移。
BMC Endocr Disord. 2022 Jan 5;22(1):12. doi: 10.1186/s12902-021-00923-2.

引用本文的文献

1
Multimodal ultrasonographic and clinicopathological model for predicting high-volume lymph node metastasis in cN0 papillary thyroid carcinoma.用于预测cN0期甲状腺乳头状癌高容量淋巴结转移的多模态超声与临床病理模型
Front Endocrinol (Lausanne). 2025 Aug 21;16:1613672. doi: 10.3389/fendo.2025.1613672. eCollection 2025.
2
Value of dynamic contrast-enhanced ultrasound in predicting cervical lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.动态对比增强超声在预测合并桥本甲状腺炎的乳头状甲状腺癌患者颈部淋巴结转移中的价值
Gland Surg. 2025 Apr 30;14(4):597-610. doi: 10.21037/gs-2024-510. Epub 2025 Apr 17.
3

本文引用的文献

1
Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients.预防性中央淋巴结清扫术可提高中高危分化型甲状腺癌患者的无病生存率:对399例患者的回顾性分析
Cancers (Basel). 2020 Jun 23;12(6):1658. doi: 10.3390/cancers12061658.
2
Sonographic Characteristics of Papillary Thyroid Carcinoma with Coexistent Hashimoto's Thyroiditis: Conventional Ultrasound, Acoustic Radiation Force Impulse Imaging and Contrast-Enhanced Ultrasound.合并桥本甲状腺炎的甲状腺乳头状癌的超声特征:传统超声、声辐射力脉冲成像及超声造影
Ultrasound Med Biol. 2019 Feb;45(2):471-480. doi: 10.1016/j.ultrasmedbio.2018.10.020. Epub 2018 Dec 8.
3
Papillary thyroid carcinoma with Hashimoto's thyroiditis: impact and correlation.
伴桥本甲状腺炎的乳头状甲状腺癌:影响及相关性
Front Endocrinol (Lausanne). 2025 Apr 11;16:1512417. doi: 10.3389/fendo.2025.1512417. eCollection 2025.
4
Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.预测合并桥本甲状腺炎的乳头状甲状腺癌中央淋巴结转移:一项术前研究
BMC Cancer. 2025 Mar 10;25(1):425. doi: 10.1186/s12885-025-13805-w.
5
A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.桥本甲状腺炎合并甲状腺乳头状癌中央区淋巴结转移的综合预测模型:BRAF 可能不是一个有价值的预测指标。
Front Endocrinol (Lausanne). 2024 Sep 19;15:1429382. doi: 10.3389/fendo.2024.1429382. eCollection 2024.
6
Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma.甲状腺微小乳头状癌患者侧方淋巴结转移及跳跃转移的预测因素
Front Endocrinol (Lausanne). 2024 Jul 2;15:1392247. doi: 10.3389/fendo.2024.1392247. eCollection 2024.
7
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.
8
Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.超声造影对甲状腺乳头状癌术前淋巴结转移的诊断价值:一项单中心回顾性研究。
BMC Surg. 2023 Oct 24;23(1):325. doi: 10.1186/s12893-023-02199-w.
9
Multimodal predictive factors of metastasis in lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma.甲状腺乳头状癌右侧喉返神经后淋巴结转移的多模态预测因素。
Front Endocrinol (Lausanne). 2023 Jul 12;14:1187825. doi: 10.3389/fendo.2023.1187825. eCollection 2023.
10
Contrast-enhanced ultrasound characteristics of preoperative central cervical lymph node metastasis in papillary thyroid carcinoma.术前甲状腺乳头状癌中央颈部淋巴结转移的超声造影特征。
Front Endocrinol (Lausanne). 2022 Sep 5;13:941905. doi: 10.3389/fendo.2022.941905. eCollection 2022.
Conventional Ultrasound, Immunohistochemical Factors and BRAF Mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.传统超声、免疫组化因素及BRAF突变在预测甲状腺乳头状癌中央区颈淋巴结转移中的作用
Ultrasound Med Biol. 2018 Nov;44(11):2296-2306. doi: 10.1016/j.ultrasmedbio.2018.06.020. Epub 2018 Aug 10.
4
Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma.建立并验证预测甲状腺乳头状癌中央区淋巴结转移的术前评分系统。
Sci Rep. 2018 May 3;8(1):6962. doi: 10.1038/s41598-018-24668-6.
5
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
6
Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules.超声造影与TI-RADS分类联合应用对甲状腺结节良恶性病变鉴别的价值
Eur Radiol. 2017 Apr;27(4):1527-1536. doi: 10.1007/s00330-016-4508-y. Epub 2016 Aug 15.
7
Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.联合应用传统超声、应变弹性成像及声辐射力脉冲(ARFI)弹性成像预测甲状腺乳头状癌患者颈部淋巴结转移
Eur Radiol. 2016 Aug;26(8):2611-22. doi: 10.1007/s00330-015-4088-2. Epub 2015 Nov 11.
8
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
9
Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes in Papillary Thyroid Cancer.术前高分辨率超声评估甲状腺乳头状癌中央区恶性淋巴结
Thyroid. 2015 Dec;25(12):1351-4. doi: 10.1089/thy.2015.0176. Epub 2015 Nov 20.
10
Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases.甲状腺微小乳头状癌的传统超声、弹性成像及超声造影特征可预测中央区淋巴结转移。
Sci Rep. 2015 Jan 13;5:7748. doi: 10.1038/srep07748.